Matthew Schwartz

Dr. Matthew Schwartz is a Radiation Oncologist with extensive experience in the Oncology and Biotechnology industries. He helped Comprehensive Cancer Centers of Nevada (CCCN) grow to over 13 offices and 57 providers. CCCN participates in over 170 phase 1, 2, and 3 clinical research studies, and he has been part of the development of 100 FDA-approved cancer therapies. Dr. Schwartz served on the Board of Directors of CCCN and was Marketing Committee Chairman. He also co-founded the Las Vegas Cyberknife, which is the premier cancer center for effective, non-invasive treatments of tumors using targeted radiation treatments. Dr. Schwartz serves as the Chairman of the Board of Managers of Las Vegas Cyberknife.

Dr. Schwartz has extensive leadership experience in the Oncology space and has served on the Radiation Oncology Leadership Council of the US Oncology Network, the US Oncology Clinical Pathways Committee, and was a member of the McKesson Specialty Health Radiation Executive Committee. He is well-versed in Precision Oncology for cancer patients.

Dr. Schwartz trained at McGill University, where he was Chief Resident, and at Yale-New Haven Hospital. He was named Alumni of the Year by the UNLV College of Sciences.